https://www.selleckchem.com/pr....oducts/pkm2-inhibito
Oral misoprostol is widely used for induction of labour (IOL) in developing countries because of its many advantages. However, limited data exist concerning its safety and efficacy when lower doses are used. To determine the safety and efficacy of a low-dose oral misoprostol regimen (commencing at 12μg) compared to a standard-dose regimen (commencing at 25μg) in Papua New Guinea (PNG) women undergoing IOL. This was an open-label non-inferiority randomised controlled trial conducted at a provincial hospital in PNG. Wom